Vitamin D-metabolizing Enzyme CYP24A1 Affects Oncogenic Behaviors of Oral Squamous Cell Carcinoma and Its Prognostic Implication

Overview

Journal Med Mol Morphol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Pathology

Date 2024 May 21

PMID 38772955

Authors

Yuna Nakamori

Akira Takasawa

Kumi Takasawa

Daisuke Kyuno

Yusuke Ono

Kazufumi Magara

Naoya Nakahashi

Shohei Sekiguchi

Kei Tsuchihashi

Akihiro Miyazaki

Makoto Osanai

Affiliations

Soon will be listed here.

Abstract

Vitamin D is an essential molecule for cellular homeostasis, playing a critical role in cell fate decisions including cell proliferation, differentiation, and viability. Accumulating evidence has revealed that expression of the vitamin D-metabolizing enzyme CYP24A1 is dysregulated in different types of human malignancy. CYP24A1 has been shown to be involved in the oncogenic property of a variety of carcinoma cells. However, the pathological relevance of CYP24A1 expression level in human oral malignancy remains to be clarified. In the present study, suppression of CYP24A1 expression in oral squamous cell carcinoma (OSCC) cells increased cell proliferation, invasive activity, colony formation efficacy, and tumor growth in vivo. In addition, knockout of CYP24A1 expression inhibited cell death induced by two different types of anticancer drugs, i.e., fluorouracil and cisplatin. Gene clustering by RNA-sequence analysis revealed that several signaling molecules associated with MYC are involved in CYP24A1-mediated oncogenic behaviors. Furthermore, decreased expression level of CYP24A1 was observed in 124/204 cases (61%) of OSCC and was shown to be associated with short relapse-free and overall survival periods. The results showed that a low expression level of CYP24A1 promotes the oncogenic activity of OSCC and is significantly associated with poor prognosis in patients with this malignancy.

References

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M . Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int J Environ Res Public Health. 2020; 17(24). PMC: 7764090. DOI: 10.3390/ijerph17249160. View

Picon H, Guddati A . Mechanisms of resistance in head and neck cancer. Am J Cancer Res. 2020; 10(9):2742-2751. PMC: 7539768. View

Bikle D . Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014; 21(3):319-29. PMC: 3968073. DOI: 10.1016/j.chembiol.2013.12.016. View

Bouillon R, Marcocci C, Carmeliet G, Bikle D, White J, Dawson-Hughes B . Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev. 2018; 40(4):1109-1151. PMC: 6626501. DOI: 10.1210/er.2018-00126. View

Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G . Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2015; 96(1):365-408. PMC: 4839493. DOI: 10.1152/physrev.00014.2015. View

Saponaro F, Saba A, Zucchi R . An Update on Vitamin D Metabolism. Int J Mol Sci. 2020; 21(18). PMC: 7554947. DOI: 10.3390/ijms21186573. View

Fernandez-Barral A, Bustamante-Madrid P, Ferrer-Mayorga G, Barbachano A, Larriba M, Munoz A . Vitamin D Effects on Cell Differentiation and Stemness in Cancer. Cancers (Basel). 2020; 12(9). PMC: 7563562. DOI: 10.3390/cancers12092413. View

Trump D, Aragon-Ching J . Vitamin D in prostate cancer. Asian J Androl. 2018; 20(3):244-252. PMC: 5952478. DOI: 10.4103/aja.aja_14_18. View

10.

Song Z, Yao Q, Zhuo Z, Ma Z, Chen G . Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis. Endocr Connect. 2018; 7(12):R294-R303. PMC: 6240137. DOI: 10.1530/EC-18-0283. View

11.

Dou R, Ng K, Giovannucci E, Manson J, Qian Z, Ogino S . Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr. 2016; 115(9):1643-60. PMC: 4890569. DOI: 10.1017/S0007114516000696. View

12.

Grimm M, Cetindis M, Biegner T, Lehman M, Munz A, Teriete P . Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC. Med Oral Patol Oral Cir Bucal. 2015; 20(2):e188-95. PMC: 4393981. DOI: 10.4317/medoral.20368. View

13.

Razak S, Afsar T, Almajwal A, Alam I, Jahan S . Growth inhibition and apoptosis in colorectal cancer cells induced by Vitamin D-Nanoemulsion (NVD): involvement of Wnt/β-catenin and other signal transduction pathways. Cell Biosci. 2019; 9:15. PMC: 6359839. DOI: 10.1186/s13578-019-0277-z. View

14.

Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M . Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother. 2018; 109:391-401. DOI: 10.1016/j.biopha.2018.10.102. View

15.

Negri M, Gentile A, de Angelis C, Monto T, Patalano R, Colao A . Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells. Nutrients. 2020; 12(6). PMC: 7353389. DOI: 10.3390/nu12061798. View

16.

Shiratsuchi H, Wang Z, Chen G, Ray P, Lin J, Zhang Z . Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma. J Thorac Oncol. 2016; 12(2):269-280. DOI: 10.1016/j.jtho.2016.10.010. View

17.

Anderson M, Nakane M, Ruan X, Kroeger P, Wu-Wong J . Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol. 2005; 57(2):234-40. DOI: 10.1007/s00280-005-0059-7. View

18.

Brozyna A, Jochymski C, Janjetovic Z, Jozwicki W, Tuckey R, Slominski A . CYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies. Int J Mol Sci. 2014; 15(10):19000-17. PMC: 4227257. DOI: 10.3390/ijms151019000. View

19.

Clinckspoor I, Hauben E, Verlinden L, Van den Bruel A, Vanwalleghem L, Vander Poorten V . Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. J Histochem Cytochem. 2012; 60(7):502-11. PMC: 3460353. DOI: 10.1369/0022155412447296. View

20.

Osanai M, Lee G . CYP24A1-induced vitamin D insufficiency promotes breast cancer growth. Oncol Rep. 2016; 36(5):2755-2762. DOI: 10.3892/or.2016.5072. View